journal article·2025-06Open access

Membrane biomimetic nanoenzyme-incorporated hybrid glycyrrhizic acid hydrogel for precise mitochondrial ROS scavenging for osteoarthritis treatment

Yong Fan, Zexuan Niu, Li Yin, Longtao Yao, Sheyuan Ding, Yu Tong, Jiao Wang, Zheping Hong, Jihang Chen, Qiong Zhang, Lichen Ji, Jiaxin Chen, Chen Xia, Qing Bi

Abstract

Osteoarthritis (OA) is a progressive degenerative disorder which severely threatens the quality of life of older individuals. OA progression is closely related to heightened levels of mitochondrial reactive oxygen species (mtROS). Although nanozymes have a good ROS-scavenging effect, they cannot precisely scavenge mtROS because of the immune rejection of cell membranes, lysosomal escape, and the inability of conventional nanozymes to directly target mitochondria. Dual-target nanozymes were engineered to precisely scavenge mtROS in chondrocytes. We used chondrocyte membrane-camouflaged TPP-modified hollow Prussian blue nanozymes and subsequently encapsulated these nanozymes in a hybrid glycyrrhizic acid hydrogel. The therapeutic efficacy and underlying mechanisms were assessed in vitro and in vivo. The novel nanozymes enhanced cell selectivity, immune evasion capabilities, and mitochondrial targeting. The dual-targeted nanozymes exerted a pronounced therapeutic impact on inflammatory chondrocytes, mitigated mtDNA leakage by precisely scavenging mtROS, dampened cGAS-STING-NF-κB signaling, and enhanced chondrocyte function. The hybrid hydrogels also exhibited improved therapeutic outcomes. We confirmed the beneficial effects of the nanozyme-hydrogel combination on OA progression in mice. The nanozyme-hydrogel combination can reduce precisely scavenge mtROS in chondrocytes, avoiding the leakage of mtDNA and suppressing the cGAS-STING-NF-κB signaling pathway, thereby decreasing inflammatory responses and alleviate OA progression.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Pharmacological Effects of Natural Compounds · Osteoarthritis Treatment and Mechanisms · Salivary Gland Disorders and Functions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (62)

Show source-provided references
1. Diagnosis and treatment of hip and knee osteoarthritis10.1001/jama.2020.22171 ↗
3. Osteoarthritis: pathogenic signaling pathways and therapeutic targets10.1038/s41392-023-01330-w ↗
4. REST, RCOR1 and RCOR2 expression is reduced in osteoarthritic chondrocytes and contributes to increasing MMP13 and ADAMTS5 expression through upregulating HES110.1016/j.cellsig.2023.110800 ↗
5. Inhibition of fibroblast activation protein ameliorates cartilage matrix degradation and osteoarthritis progression10.1038/s41413-022-00243-8 ↗
6. Intra-articular treatment options for knee osteoarthritis10.1038/s41584-018-0123-4 ↗
7. The cell biology of mitochondrial membrane dynamics10.1038/s41580-020-0210-7 ↗
8. Mitochondrial dysfunction in cardiac aging10.1016/j.bbabio.2015.07.009 ↗
9. LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis10.1038/s41467-020-17242-0 ↗
10. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis10.1038/s41584-020-00533-7 ↗
11. Nano‐brake halts mitochondrial dysfunction cascade to alleviate neuropathology and rescue alzheimer's cognitive deficits10.1002/advs.202204596 ↗
12. Mitochondrial DNA variation and the pathogenesis of osteoarthritis phenotypes10.1038/s41584-018-0001-0 ↗
13. Interleukin-1β induces mtDNA release to activate innate immune signaling via cGAS-STING10.1016/j.molcel.2019.02.038 ↗
14. Nitisinone attenuates cartilage degeneration and subchondral osteoclastogenesis in osteoarthritis and concomitantly inhibits the cGAS/STING/NF-κB pathway10.1016/j.ejphar.2024.176326 ↗
15. DNA damage and repair in age-related inflammation10.1038/s41577-022-00751-y ↗
16. Intra‐articular injection of nanomaterials for the treatment of osteoarthritis: from lubrication function restoration to cell and gene therapy10.1002/adfm.202401547 ↗
17. Nerve–bone crosstalk manipulates bone organoid development and bone regeneration: a review and perspectives10.36922/or.8294 ↗
18. Effect of radiation sterilisation on the structure and antibacterial properties of antimicrobial peptides
19. Targeted and responsive biomaterials in osteoarthritis10.7150/thno.78639 ↗
20. Nanozymes: classification, catalytic mechanisms, activity regulation, and applications10.1021/acs.chemrev.8b00672 ↗
21. Prussian blue nanoparticles as multienzyme mimetics and reactive oxygen species scavengers10.1021/jacs.5b12070 ↗
22. Excavating bioactivities of nanozyme to remodel microenvironment for protecting chondrocytes and delaying osteoarthritis
23. Nanomaterial designing strategies related to cell lysosome and their biomedical applications: a review10.1016/j.biomaterials.2019.05.002 ↗
24. A plant-derived natural photosynthetic system for improving cell anabolism10.1038/s41586-022-05499-y ↗
25. Mitochondrial targeted strategies and their application for cancer and other diseases treatment10.1007/s40005-020-00481-0 ↗
26. Exosome‐based mitochondrial delivery of circRNA mSCAR alleviates sepsis by orchestrating macrophage activation10.1002/advs.202205692 ↗
27. Piezocatalytic 2D WS2 nanosheets for ultrasound‐triggered and mitochondria‐targeted piezodynamic cancer therapy synergized with energy metabolism‐targeted chemotherapy
28. Encapsulated metal nanoparticles for catalysis10.1021/acs.chemrev.0c00237 ↗
29. Articular cartilage repair biomaterials: strategies and applications10.1016/j.mtbio.2024.100948 ↗
30. Silk fibroin-based biomaterials for cartilage/osteochondral repair10.7150/thno.74548 ↗
31. A comparative study of human and porcine-derived decellularised nerve matrices
32. Silk fibroin-based hydrogels for cartilage organoids in osteoarthritis treatment10.7150/thno.103491 ↗
33. Cartilage-on-chip for osteoarthritis drug screening10.36922/or.8461 ↗
34. Treatment with mesenchymal stem cell‐derived nanovesicle‐containing gelatin methacryloyl hydrogels alleviates osteoarthritis by modulating chondrogenesis and macrophage polarization
35. Research progress in hydrogels for cartilage organoids10.1002/adhm.202400431 ↗
36. Diterbutyl phthalate attenuates osteoarthritis in ACLT mice via suppressing ERK/c-fos/NFATc1 pathway, and subsequently inhibiting subchondral osteoclast fusion10.1038/s41401-021-00747-9 ↗
37. Cancer-cell-membrane-coated nanoparticles with a yolk–shell structure augment cancer chemotherapy10.1021/acs.nanolett.9b03817 ↗
38. Active-oxygenating hollow Prussian blue nanosystems loaded with biomacromolecules for photodynamic/photothermal therapy of cancer and alleviating hypoxic tumors
39. Reprogramming mitochondrial metabolism in synovial macrophages of early osteoarthritis by a camouflaged meta‐defensome10.1002/adma.202202715 ↗
40. Fumarate induces vesicular release of mtDNA to drive innate immunity10.1038/s41586-023-05770-w ↗
41. Exosomal transfer of osteoclast-derived miRNAs to chondrocytes contributes to osteoarthritis progression10.1038/s43587-021-00050-6 ↗
42. The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mouse10.1016/j.joca.2010.05.025 ↗
43. Mechanisms of phagocytosis in macrophages10.1146/annurev.immunol.17.1.593 ↗
44. Macrophages in immunoregulation and therapeutics10.1038/s41392-023-01452-1 ↗
45. Fusion dynamics of cubosome nanocarriers with model cell membranes10.1038/s41467-019-12508-8 ↗
46. Recent progress in targeted delivery vectors based on biomimetic nanoparticles10.1038/s41392-021-00631-2 ↗
47. Membrane-coated nanoparticles as a biomimetic targeted delivery system for tumour therapy
48. Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis10.1126/scitranslmed.adh9751 ↗
49. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
50. Thermosensitive hydrogel incorporating prussian blue nanoparticles promotes diabetic wound healing via ROS scavenging and mitochondrial function restoration10.1021/acsami.1c24569 ↗
51. Cartilage progenitor cells derived extracellular vesicles-based cell-free strategy for osteoarthritis treatment by efficient inflammation inhibition and extracellular matrix homeostasis restoration10.1186/s12951-024-02632-z ↗
52. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release10.1152/physrev.00026.2013 ↗
53. Molecular mechanisms and consequences of mitochondrial permeability transition10.1038/s41580-021-00433-y ↗
54. Prohibitin 1 regulates mtDNA release and downstream inflammatory responses10.15252/embj.2022111173 ↗
55. Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions10.1038/s41392-024-01852-x ↗
56. Immunoregulation in diabetic wound repair with a photoenhanced glycyrrhizic acid hydrogel Scaffold10.1002/adma.202200521 ↗
57. Biomedical applications of gelatin methacryloyl hydrogels10.1016/j.engreg.2021.03.002 ↗
58. Restoring articular cartilage: insights from structure, composition and development10.1038/s41584-025-01236-7 ↗
59. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis10.1038/nrrheum.2016.136 ↗
60. Endogenous stimuli-responsive separating microneedles to inhibit hypertrophic scar through remodeling the pathological microenvironment
61. STING promotes senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the NF-κB signaling pathway10.1038/s41419-020-03341-9 ↗
62. Moderate mechanical stress suppresses chondrocyte ferroptosis in osteoarthritis by regulating NF-κB p65/GPX4 signaling pathway